Health & Medicine
-
Powerful New Synthetic Vaccines to Combat Epidemics
A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings, published in Science Advances today [Wednesday 25 September], reveal exceptionally promising results for the Chikungunya vaccine candidate, which has been engineered using a synthetic protein scaffold that could revolutionize the way vaccines are designed, produced and stored.
Latest Research Articles
-
Mummy Study: Heart Disease Was Bigger Issue for Human Ancestors Than Initially Thought
-
Discovery of Novel Cancer Signaling Mechanism And Design of New Anticancer Compound
-
Researchers Perform Thousands of Mutations to Understand Amyotrophic Lateral Sclerosis
-
For People with Pre-Existing Liver Disease, Toxic Algae May Be More Dangerous
-
Malawi Study Confirms Lasting Impact of Life-Saving Technology
-
US Pediatric Heart Transplant Waitlist Policy Change Falls Short of Intended Benefits
-
New Insight as to How Cells Maintain Their Identity
-
The Benefits Of Research When Looking Into Hair Transplants
-
Instant Messaging In Proteins Discovered
-
Study Points to New Drug Target in Fight Against Cancer
-
Researchers Develop Thermo-Responsive Protein Hydrogel
-
Stevens Researchers to Develop Handheld Device to Diagnose Skin Cancer